Want to see DE:RHK full AI Analyst Report?
RHK Stock Chart & Stats
€12.90
€0.20(1.57%)
At close: 4:00 PM EDT
€12.90
€0.20(1.57%)
Day’s Range― - ―
52-Week Range€11.30 - €15.70
Previous CloseN/A
Volume551.00
Average Volume (3M)955.00
Market Cap
€990.69M
Enterprise Value€889.42
Total Cash (Recent Filing)€578.26M
Total Debt (Recent Filing)€112.47M
Price to Earnings (P/E)24.7
Beta-0.03
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.35%
Share Statistics
EPS (TTM)0.60
Shares Outstanding66,962,470
10 Day Avg. Volume528
30 Day Avg. Volume955
Financial Highlights & Ratios
PEG Ratio-1.22
Price to Book (P/B)0.64
Price to Sales (P/S)0.44
P/FCF Ratio-24.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.64
Revenue Forecast (FY)€1.79B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and rising equity (total equity ~€1.32bn; debt down to ~€122m) provide RHÖN-KLINIKUM a durable financial cushion. This reduces refinancing risk, supports measured capital spending or strategic acquisitions, and preserves flexibility to absorb operational shocks over several quarters.
Hospital Network & Service MixA diversified network of hospitals delivering inpatient and outpatient care across multiple specialties yields recurring, non-cyclical revenues. That breadth supports steady patient demand, cross-referrals and utilization stability, helping revenue resilience and operational leverage over the medium term.
Episodes Of Strong Revenue GrowthRepeatable top-line expansions in 2023 and 2025 show the business can scale volumes or pricing when conditions allow. If management sustains those drivers (volume mix, capacity use, or service mix), the company can rebuild operating leverage and improve long-term revenue trends despite occasional down years.
Bears Say
Sharp Operating Profit DeclineA collapse in EBIT from ~€48m to ~€4m signals significant cost pressure, one-off charges, or operational disruption that materially erodes core profitability. Such a swing reduces internal funding capacity, weakens margin stability and may point to structural cost or pricing challenges over the coming quarters.
Deteriorating Cash GenerationA material drop in operating cash flow and a swing to negative free cash flow reduce internal financing for capex, working capital and strategic initiatives. If negative FCF persists, the company may need external funding, cutbacks, or delayed investments, increasing funding risk over multiple quarters.
Thin Margins And Low ROELow net and EBITDA margins, coupled with low-single-digit ROE, indicate limited profitability on deployed capital. Thin margins leave little buffer against cost inflation or reimbursement pressure and constrain the firm's ability to generate strong returns or reinvestment capacity over the medium term.
RHK FAQ
What was RHON-KLINIKUM AG’s price range in the past 12 months?
RHON-KLINIKUM AG lowest stock price was €11.30 and its highest was €15.70 in the past 12 months.
What is RHON-KLINIKUM AG’s market cap?
RHON-KLINIKUM AG’s market cap is €990.69M.
When is RHON-KLINIKUM AG’s upcoming earnings report date?
RHON-KLINIKUM AG’s upcoming earnings report date is Nov 05, 2026 which is in 84 days.
How were RHON-KLINIKUM AG’s earnings last quarter?
RHON-KLINIKUM AG released its earnings results on Aug 06, 2026. The company reported €0.135 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is RHON-KLINIKUM AG overvalued?
According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued.
Does RHON-KLINIKUM AG pay dividends?
RHON-KLINIKUM AG pays a Annually dividend of €0.2 which represents an annual dividend yield of 1.35%. See more information on RHON-KLINIKUM AG dividends here
What is RHON-KLINIKUM AG’s EPS estimate?
RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RHON-KLINIKUM AG have?
RHON-KLINIKUM AG has 66,962,470 shares outstanding.
What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?
RHON-KLINIKUM AG reported an EPS of €0.135 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.587%.
Which hedge fund is a major shareholder of RHON-KLINIKUM AG?
Currently, no hedge funds are holding shares in DE:RHK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
RHON-KLINIKUM AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.63%
12-Months-Change
Fundamentals
Return on Equity
1.35%
Trailing 12-Months
Asset Growth
-1.58%
Trailing 12-Months
Company Description
RHON-KLINIKUM AG
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.
Technical Analysis
Fresenius Medical Care AG & Co. KGaA
―
MEDICLIN
―
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
M1 Kliniken AG
―